United Kingdom · Advertising framework
Email, SMS and direct-message marketing for medical treatments and services in the United Kingdom
General market orientation, not campaign clearance. Research scope and dates
Product and service rules
Evidence and professional competence apply to treatment promotion
Regulator guidance
CAP section 12 requires evidence for objective health claims and suitable professional supervision where medical attention is needed. Do not discourage essential treatment. Check the relevant professional and provider regulator in addition to the advertising code.
Sources: CAP Code section 12: medicines, devices, health and beauty
Avoid pressure tactics and procedure prizes
Regulator guidance
Applies when: A GMC-regulated professional markets cosmetic interventions.
GMC standards require factual, checkable information, realistic outcomes and clear notice of a required medical assessment. Do not trivialise risks or present an intervention as risk-free.
Do not use tactics that encourage an ill-considered decision or offer the service as a prize. The professional must not knowingly let another party misrepresent the service in conflict with these standards.
Sources: GMC — Cosmetic interventions professional standards
Do not use waiting lists to promote unlicensed or prescription weight-loss medicines
Regulator guidance
Applies when: The offer concerns prescription or unlicensed weight-management medicines.
The June 2026 joint warning expressly identifies promotion of pipeline weight-management products, waiting lists and newly licensed oral GLP-1 medicines. Product novelty or a waiting-list sign-up does not remove the public-advertising restriction.
Assess the overall message of a clinic or pharmacy campaign, including indirect medicine references and its linked destination.
Sources: MHRA, ASA and GPhC — Warning on weight-management medicine promotion, 18 June 2026
Channel rules
Check the complete consumer-facing message
Regulator guidance
The DMCC consumer-protection regime addresses misleading claims, deceptive overall presentation and material omissions. Support factual statements with evidence and present important conditions in time for an informed decision. Review prices, qualifications and commercial intent alongside the health-sector requirements.
Sources: Unfair commercial practices: CMA207
Check subscriber type and the actual soft opt-in conditions
Regulator guidance
PECR normally requires consent for electronic marketing to individual subscribers unless an applicable soft opt-in is satisfied. Corporate subscribers follow a different route. Identify the sender and provide an opt-out. Social direct messages can be electronic mail; distinguish these from public posts.
Separate promotional and service messages
Editorial recommendation
Review the rules for the actual delivery method: email, SMS and private social messages are not interchangeable. Keep the relevant permission record, accurate sender details and a working suppression process.
Campaign workflow
Medical Treatments & Services: prepare the review
Editorial recommendation
Define the actual treatment and who is authorised to provide it. Separate evidence of a possible benefit from a promise of an individual result. Explain material limits, costs and eligibility without creating pressure for unnecessary care.
Keep a traceable campaign decision
Editorial recommendation
Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.
Pre-publication checklist
- Define the actual treatment and who is authorised to provide it.
- Separate evidence of a possible benefit from a promise of an individual result.
- Explain material limits, costs and eligibility without creating pressure for unnecessary care.
- Record product or provider eligibility before approving claims.
- Archive the final creative and its evidence, permissions and review decisions.
- Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.
Scope and unresolved questions
- Windsor medicine licensing and the GB/NI device distinction are now documented. Verify the exact authorisation, certificate validity, transitional eligibility and destination market. Food-claim transitions, other professional regulators and broadcaster-specific clearance remain separate checks.
- This national baseline does not review every broadcaster rule, platform policy, regional licensing condition, promotion mechanic or data-transfer arrangement. No format-specific warning dimensions or durations should be inferred where none are supplied.
Research scope, introduction and dates
Promoting a medical treatment by email, SMS and direct messages in the United Kingdom requires a precise description of the service and who provides it. Connect the evidence for possible benefits with realistic patient expectations and the applicable professional advertising conditions.
Email, SMS and private platform messages can follow different permission rules. Identify the delivery technology and the recipient relationship, then review the promotional content and withdrawal process separately.
General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.
How to use this national baseline
Editorial overview
This framework combines researched national rules with editorial review steps. UK advertising baseline with a required Great Britain versus Northern Ireland product-regime check. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.
The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.
Sources
- CAP Code section 12: medicines, devices, health and beauty
Use the operative rules; the page’s historical device-transition dates are not used as current market-access guidance. Broadcast advertisements require BCAP review.
- Unfair commercial practices: CMA207
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- Direct marketing using electronic mail
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- GMC — Cosmetic interventions professional standards
Targeted review on 25 October 2026. This date does not certify the currency of other sources or resolve local and campaign-specific requirements.
- MHRA, ASA and GPhC — Warning on weight-management medicine promotion, 18 June 2026
Targeted review on 25 October 2026. This date does not certify the currency of other sources or resolve local and campaign-specific requirements.
From framework to action
Local expertise in United Kingdom
Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in United Kingdom.
Medical & health marketing
No partners listed in this category yet.
Marketing & sales advisory
No partners listed in this category yet.
Business & project coordination
No partners listed in this category yet.
Join the local partner directory
Would you like your company to be listed?
Talk to us about the terms of a listing. Leave your details and we will get in touch.